For those sites using BD Alaris pumps, has your organization opted to move forward with the System software update (to v12.1.2) ahead of official FDA clearance? If so, is your organization planning any sort of specific surveillance of these devices?

Appreciate your insight!

Greetings,

Does anybody have a system-level policy/process regarding management of recalls for pharmaceuticals, medical equipment/devices, etc they could share? I’m specifically interested in any policies/mechanisms that include requirements for individual facilities to report back to system leadership about recall impact and actions taken in response to a recall (e.g., quantity on hand, quantity unaccounted for, removal of product from stock completed, # of patients affected, level of patient harm, was patient notification necessary, patient notification completed).